Cardiopulmonary Bypass Equipment Market is Estimated to Witness High Growth Owing to Opportunity in Rising Prevalence of Cardiovascular Diseases

Cardiopulmonary Bypass Equipment Market



Cardiopulmonary bypass equipment play a vital role in cardiovascular surgeries such as coronary artery bypass graft surgery (CABG) by performing the function of heart and lungs during an operation. These equipments help sustain the patient's life by pumping oxygen-rich blood throughout the body and removing carbon dioxide from the blood during surgery. They consist of components such as oxygenators, pumps, cannula, and tubing sets which enables diverting blood around the heart and lungs through an extracorporeal circuit. Growing prevalence of cardiovascular diseases and rising cases of coronary artery bypass graft surgery have boosted the demand for reliable cardiopulmonary bypass equipment worldwide.


The global Cardiopulmonary Bypass Equipment Market is estimated to be valued at US$ 120.01 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:


The rising prevalence of cardiovascular diseases is one of the major opportunities fueling the growth of the cardiopulmonary bypass equipment market. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. With growing cases of coronary artery disease, cerebrovascular disease and rheumatic heart disease, the demand for cardiovascular operations involving cardiopulmonary bypass equipment is also accelerating. With rapid technological advancements, manufacturers are introducing novel equipments integrated with advanced features which reduces complication risks and improves safety during surgeries. The development of portable miniaturized cardiopulmonary bypass systems further amplifies their adoption rate across healthcare facilities. Thus increasing incidence of heart conditions provides significant scope for cardiopulmonary bypass equipment manufacturers over the forecast period.

Porter’s Analysis

Threat of new entrants: The cardiopulmonary bypass equipment market requires high R&D investment and regulatory approvals which increases entry barriers for new players.

Bargaining power of buyers: The bargaining power of buyers is moderate as customers have multiple product and brand options to choose from.

Bargaining power of suppliers: A few major players dominate the supply side giving them significant influence over pricing.

Threat of new substitutes: There exists a low threat from substitutes as cardiopulmonary bypass equipment is an important component in cardiac surgeries with no close substitutes.

Competitive rivalry: The market sees intense competition among existing players to gain market share through product innovation and quality.

SWOT Analysis

Strength: Advanced technologies like miniaturized systems and centrifugal pumps have improved portability and efficiency. Growing demand for cardiac surgeries is a key strength.

Weakness: High costs associated with R&D, regulatory standards and recalls limit affordability. Lack of skilled professionals in some regions.

Opportunity: Rising geriatric population prone to cardiovascular diseases presents lucrative growth prospects. Emerging economies offer untapped market potential.

Threats: Stringent regulatory approvals and recalls delay market entry. Political, economic and trade dynamics impact business environment.

Key Takeaways


Global Cardiopulmonary Bypass Equipment Market Size is expected to witness high growth over the forecast period driven by growing number of cardiac surgical procedures worldwide. The global Cardiopulmonary Bypass Equipment Market is estimated to be valued at US$ 120.01 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.

The North American region currently dominates the market attributed to increasing incidence of cardiovascular diseases and technological advancements. Asia Pacific region indicates expanding patient pool, rising healthcare spending, and growing medical tourism industry will fuel the market growth during the projection period.

Key players operating in the cardiopulmonary bypass equipment market are Dow, Henkel, BASF, Nordson, LORD Corporation, H.B. Fuller, Siltech Corporation, Qualcomm, Broadcom, Skyworks Solutions, Qorvo. Dow and Medtronic hold a major market share backed by their diversified product portfolio and strong global presence. Increasing mergers and acquisitions strategy helps strengthen their product offerings across regions.


Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Global Methyl & Ethyl Chloroacetate Market Is Expected To Register A Cagr Of 7.9% In Terms Of Revenue Over The Forecast Period (2019-2027)

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027